Organon announces agreement to divest its JADA System for treating postpartum hemorrhage for up to $465 Million to Laborie
Organon announced that it has entered into an agreement with Laborie Medical Technologies Corp., a leading diagnostic and therapeutic medical technology company, for them to acquire the JADA… read more.
